NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01949129,Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia,https://clinicaltrials.gov/study/NCT01949129,,RECRUITING,"The ALL SCTped 2012 FORUM is a multinational, multi-centre, controlled, prospective phase III study for the therapy and therapy optimisation for children and adolescents with ALL in complete morphological remission (CR, less than 5% bone marrow blasts, no blasts in cerebrospinal fluid, no other extramedullary leukemia), who have an indication for HSCT with a myeloablative conditioning regimen.

The stratification of patients in first and following remissions according to the individual transplantation modalities rests upon an indication for allogeneic HSCT and the availability of a suitable donor within the individual transplantation groups.",NO,Acute Lymphoblastic Leukaemia,DRUG: VP16|RADIATION: TBI|DRUG: Thiotepa|DRUG: Treosulfan|DRUG: Fludarabine|DRUG: Busulfan|DRUG: ATG Thymoglobulin|DRUG: Cyclophosphamide|DRUG: Grafalon,"Overall Survival (OS) Stratum 1a (randomisation TBI+ chemo-conditioning vs. chemo-conditioning only), Stratum 1 - randomisation related question was closed in December 2018; patients are in active follow-up: To show that a non total body irradiation (TBI) containing conditioning (Flu/Thio/ivBu or Flu/Thio/Treo) results in a non-inferior survival as compared to conditioning with TBI/Etoposide in children older than 4 years after HSCT from a Human leucocyte antigen (HLA) identical sibling donor (MSD) or a HLA matched donor (MD). The primary endpoint is the OS calculated from the date of the randomisation. Death from any cause will be considered an event., first: 18 months after inclusion of first patient, afterwards annually up to 10 years|Event free survival (EFS) Stratum 2 (mismatched donor transplantation), EFS after allogeneic HSCT. EFS calculated from date of recruitment to disease progression or relapse, secondary neoplasm and death from any cause., first: 18 months after inclusion of first patient, afterwards annually up to 10 years|Overall Survival (OS), Stratum 1b: MSD/MD without randomisation, To explore the impact of risk factors on the incidence of adverse events of special interest (AESIs) and on overall survival and event free survival in the entire MSD/MD cohort, first: 18 months after inclusion of first patient, afterwards annually up to 10 years","EFS (Stratum 1a and 1b), EFS calculated from date of randomization (1a) or recruitment (1b) to disease progression or relapse, secondary neoplasm and death from any cause. Patients lost to follow-up without event will be censored at the date of their last follow-up evaluation., first: 18 months after inclusion of first patient, afterwards annually up to 10 years|TRM, Cumulative Incidence of Treatment-related mortality (TRM) for Stratum 1 and 2., first: 18 months after inclusion of first patient, afterwards annually up to 10 years|Relapse/progression, Cumulative Incidence of Relapse for Stratum 1a, 1b and 2., first: 18 months after inclusion of first patient, afterwards annually up to 10 years|Acute and late toxicity for Stratum 1a, 1b and 2, according a preselection out of CTC3, first: 18 months after inclusion of first patient, afterwards annually up to 10 years|OS (Stratum 2), The primary endpoint is the OS calculated from the date of the recruitment . Death from any cause will be considered an event., first: 18 months after inclusion of first patient, afterwards annually up to 10 years","Acute Graft versus Host Disease (aGVHD), According to the modified Seattle Glucksberg criteria, first: 18 months after inclusion of first patient, afterwards annually up to 10 years|Secondary malignancies, Incidence, type and timepoint of occurence, first: 18 months after inclusion of first patient, afterwards annually up to 10 years|Chronic Graft-versus-host disease (cGvHD), Chronic GVHD is diagnosed using criteria created through the NIH consensus development project, first: 18 months after inclusion of first patient, afterwards annually up to 10 years",St. Anna Kinderkrebsforschung,ALL SCTped Forum|European Society for Blood and Marrow Transplantation|ALL-BFM Study Group|Assistance Publique - Hôpitaux de Paris|Dutch Childhood Oncology Group|Swiss Pediatric Oncology Group|Australian & New Zealand Children's Haematology/Oncology Group,ALL,"CHILD, ADULT",PHASE2|PHASE3,1800,OTHER,INTERVENTIONAL,Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,ALL SCTped FORUM 2012,2013-04,2025-06,2030-04,2013-09-24,,2024-01-16,"Hospital de Pediatria ""Juan P. Garrahan"" Combate de Los Pozos N°1800 CABA, Buenos Aires, Argentina|Hospital Sor Maria Ludovica, Department Hematology Stem Cell Transplant Unit, La Plata, 1651, Argentina|Children's Cancer Centre The Royal Children's Hospital, Melbourne, 3052, Australia|Princess Margaret Hospital for Children, Perth, 6008, Australia|Sydney Children's Hospital, Randwick, 2031, Australia|Lady Cilento Children's Hospital, South Brisbane, 4101, Australia|The Children's Hospital at Westmead Oncology Unit, Sydney, 2145, Australia|Universitätsklinik für Kinder- und Jugendheilkunde, Abt. f. Hämato-Onkologie, Graz, 8036, Austria|Universitätsklinik für Kinder- und Jugendheilkunde, Innsbruck, 6020, Austria|St. Anna Children's Hospital, Vienna, Austria, Vienna, 1090, Austria|Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus|Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Brussels, 1020, Belgium|Cliniques Universitaires Saint-Luc (UCL) Hématologie et oncologie pédiatrique, Brussels, 1200, Belgium|University Hospital Gent Pediatrische hemato-oncologie, Gent, 9000, Belgium|University Hospitals Leuven Kinderhemato-oncologie, Leuven, 3000, Belgium|Centre Hospitalier Universitaire de Liège Domaine Universitaire du Sart Tilman, Liège, Belgium|Alberta Children's Hospital Division of Pediatric Oncology, Calgary, Canada|Montreal Children's Hospital, Montral, Canada|CHU Sainte-Justine Hematology-Oncology Division, Montreal, Canada|Hospital for Sick Children University of Toronto Division of Haematology/Oncology, Toronto, Canada|BC Children's Hospital, Vancouver, Canada|CancerCare Manitoba/University of Manitoba, Winnipeg, Canada|Hospital Dr Luis Calvo Mackenna, Santiago, Chile|Department of Pediatrics, UHC Zagreb, Zagreb, Croatia|Department of Pediatric Hematology and Oncology Teaching Hospital Motol, 2nd Medical School, Charles University, Prague, 150 06, Czechia|Paediatric Stem Cell Transplant and Immune Deficiency, Dept. for children and adolescents 4072, Rigshospitalet, Copenhagen, 2100, Denmark|Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, Univ. of Helsinki, Helsinki, 00029 HUS, Finland|CHU Bordeaux, Bordeaux, 33076, France|CHU Clermont-Ferrand, Clermont-Ferrand, 63003, France|CHU Grenoble - Clinique Universitaire de Pédiatrie, Hôpital Couple Enfant, Grenoble, 38043, France|CHRU Lille, Service d'Hématologie Pédiatrique, Lille, 59037, France|IHOP / Lyon, Service Hématologie et d'Oncologie pédiatrique, Lyon, 69372, France|Hopital la Timone Adulte, Marseille, 13385, France|Hopital Arnaud de Villeneuve, Montpellier, 34295, France|CHU Nancy - Hopital d'Enfants, Nancy, 54500, France|CHU Nantes, Service d'onco hémato pédiatrie, Nantes, 44093, France|Hôpital Robert Debré, Paris, 75019, France|CHU de Rennes, Serive d'Onco-Pédiatrie, Rennes, 35203, France|CHU de Rouen, Hopital des Enfants, Service d' Immuno-Hématologie Oncologie Pédiatrique, Rouen, 76031, France|CHU Strasbourg, Service d'hématologie et d'oncologie pédiatrique, Strasbourg, 67098, France|Uniklinik RWTH Aachen, Kinder- und Jugendmedizin, Aachen, 52074, Germany|Charité - Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, 13353, Germany|Universitätsklinikum Bonn, Abteilung für Pädiatrische Hämatologie und Onkologie, Bonn, 53113, Germany|Universitätsklinikum Düsseldorf, Klinik für Kinder-Onkologie, -Hämatologie und Klinische Immunologie, Düsseldorf, 40225, Germany|Universitätsklinikum Erlangen, Kinder- und Jugendklinik, Erlangen, 1054, Germany|Universitätsklinikum Essen, Klinik für Kinderheilkunde III, Essen, 45122, Germany|Klinikum der Johann Wolfgang Goethe-Universität, Klinik für Kinder- und Jugendmedizin (KKJM), Frankfurt am Main, 60590, Germany|Universitätsklinikum Freiburg, Zentrum für Kinder- und Jugendmedizin, Freiburg, 79106, Germany|Universitätsklinikum Gießen, Zentrum für Kinder- und Jugendmedizin, Gießen, 35392, Germany|Universitätsmedizin Greifswald, Klinik und Poliklinik für Kinder- und Jugendmedizin, Greifswald, 17475, Germany|Universitätsklinikum Halle (Saale), Universitätsklinik und Poliklinik für Kinder- und Jugendmedizin, Halle, 06120, Germany|Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Pädiatrische Hämatologie und Onkologie, Hamburg, 20246, Germany|Medizinische Hochschule Hannover, Zentrum Kinderheilkunde und Jugendmedizin, Hannover, 30625, Germany|Universitätsklinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin, Heidelberg, 69120, Germany|Universitätsklinikum Jena, Sektion für Stammzelltransplantation, Jena, 07745, Germany|UKSH - Universitätsklinikum Schleswig-Holstein, Klinik für Allgemeine Pädiatrie, Kiel, 24105, Germany|Universitätsmedizin Leipzig, Abteilung für Pädiatrische Onkologie, Hämatologie und Hämostaseologie, Leipzig, 04103, Germany|Klinikum der Universität München, Dr. von Haunersches Kinderspital, München, 80337, Germany|Städt. Krankenhaus München Schwabing, Universitätskinderklinik der TU München, München, 80804, Germany|Universitätsklinikum Münster, Klinik für Kinder- und Jugendmedizin, Münster, 48149, Germany|Universitätsklinikum Regensburg, Klinik und Poliklinik für Kinder- und Jugendmedizin, Regensburg, 93053, Germany|Universitätsklinik für Kinder- und Jugendmedizin Tübingen, Tübingen, 72076, Germany|Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Ulm, 89075, Germany|Universitäts-Kinderklinik Würzburg, Würzburg, 97080, Germany|Saint Sophia Children's Hospital BMT Unit, Athens, 11527, Greece|National Institute of Haematology and Infectious Disease, Hospital of Southern Pest, Paediatric Bone Marrow Transplantation Unit, Budapest, 1097, Hungary|Rambam Medical Center, Haifa, 31096, Israel|Schneider Children's Medical Center of Israel, Petach-Tikva, 49202, Israel|Dana Children's Hospital, Tel Aviv, 64239, Israel|Azienda Ospedaliero-Universitaria Policlinico S. Orsola-Malpighi di Bologna, Bologna, 40138, Italy|Ospedale Mayer di Firenze SODc Tumori Pediatrici e TMO, Florence, 50139, Italy|Istituto Gaslini Genova Oncoematologia Pediatrica-, Genoa, 16147, Italy|A.O. San Gerardo di Monza Clinica Pediatrica, Monza, 20900, Italy|A.O.R.N. Santobono Pausilipon, Dipartimento di Oncoematologia, Napoli, 80123, Italy|Azienda Ospedaliera di Padova Oncoematologia Pediatrica, Padova, 35128, Italy|Fondazione IRCCS Policlinico San Matteo, Pavia, 27100, Italy|Azienda Ospedaliero Universitaria Pisana U.O. di Oncoematologia Pediatrica A.O., Pisa, 56126, Italy|Ospedale Pediatrico Bambino Gesù, Sapienza, University of Rome, Rome, 00165, Italy|Ospedale Infantile Regina Margherita SC Oncoematologia e Centro Trapianti, Torino, 10126, Italy|University of Malaya, Department of Paediatrics, Kuala Lumpur, Malaysia|Instituto Nacional de Peditria, Ciudad de México, Mexico|Leiden University Medical Center Department of Pediatrics/BMT unit, Leiden, 2300, Netherlands|Princess Máxima Center for Pediatric Oncology, Utrecht, 3584, Netherlands|Starship Children's Hospital, Auckland, 1142, New Zealand|Oslo University Hospital Rikshospitalet, Oslo, 0424, Norway|University Hospital No.1, Collegium Medicum UMK, department of Paediatrics, Oncology, Hematology and Paediatric Transplantology, Bydgoszcz, Poland|University Children's Hospital in Krakow, Department of Transplantation, Kraków, Poland|Children's University Hospital, Dept. Pediatric Hematology, Oncology, and Transplantology, Lublin, Poland|Poznan University of Medical Sciences, Department of Pediatric Onology, Hematology & HSCT, Poznań, Poland|Cape of Hope, Wroclaw Medical University, Wrocław, Poland|IInsitutul Clinic Fundeni, Sectia de Transplant Medular, Bukarest, Romania|University of Medicine and Pharmacy V. BABES, Emergency Children's Hospital LOUIS TURCANU, III. Clinic of Pediatrics , Department of Onco-hematology and Bone Marrow Transplantation, Timişoara, Romania|King Abdullah specialists children hospital, Riyadh, Saudi Arabia|University Children's Hospital, Bratislava, 83340, Slovakia|University childrens' hospital, UMCL, Ljubljana, Slovenia|Hospital Santa Creu i Sant Pau, Barcelona, Spain|Hospital Vall d'Hebron, Barcelona, Spain|Hospital Virgen de la Arrixaca, Murcia, Spain|Hospital Materno Infantil de Málaga, Málaga, Spain|Hospital Universitario Central de Asturias, Oviedo, Spain|Queen Silvia Children's Hospital, Department of Pediatric Oncology (Avdelnig 321-322), Göteborg, 41685, Sweden|Skane University Hospital, Dept. of Pediatrics, Section for Hematology and Oncology, Lund, 22185, Sweden|Karolinska University Hospital, Department of Pediatrics, Stockholm, 14186, Sweden|University Children's Hospital, Dept. of Women's & Children's Health Section for Pediatrics, Uppsala, 75185, Sweden|Universitäts-Kinderspital beider Basel (UKBB), Basel, 4056, Switzerland|HUG Hôpitaux Universitaire de Genève, Geneva, 1211, Switzerland|Universitäts-Kinderspital Zurich, Zurich, 8032, Switzerland|Ankara University School of Medicine Pediatric Stem Cell Transplantation Unit, Ankara, 06100, Turkey|Gazi University School of Medicine Pediatric Stem Cell Transplantation Unit, Ankara, Turkey|Gülhane Training and Research Hospital, Ankara, Turkey|Akdeniz University School of Medicine Pediatric Stem Cell Transplantation Unit, Antalya, Turkey|Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit, Antalya, Turkey|Acibadem University Atakent Hospital Pediatric Stem Cell Transplantation Unit, Istanbul, Turkey|Bahcelievler Medicalpark Hospital Pediatric Stem Cell Transplantation Unit, Istanbul, Turkey|Bahcesehir University School of Medicine Pediatric Stem Cell Transplantation Unit, Istanbul, Turkey|Medipol Mega Üniversite Hastanesi, Istanbul, Turkey|Dokuzeylul University School of Medicine Pediatric Stem Cell Transplantation Unit, Izmir, Turkey|Ege University School of Medicine Pediatric Stem Cell Transplantation Unit, Izmir, Turkey|Erciyes University School of Medicine Pediatric Stem Cell Transplantation Unit, Kayseri, Turkey",
